Day: May 9, 2022

EfTEN Capital AS (registry code 11505542, address A. Lauteri tn 5, 10114 Tallinn) as the management company of the EfTEN United Property Fund announces a public offering of the units of the EfTEN United Property Fund. Offering of units The Management Company organizes the offering of up to 500,000 fund units to all natural and legal persons in Estonia in accordance with the public offering prospectus of the units. The offer is divided to interim periods. During the first interim period, i.e. from 9.00 am (EET) on 09.05.2022 to 11.00 am on 20.05.2022 (EET), the Management Company will offer and the Fund will issue 460,000 offered units. The Management Company has the right to increase the offer by 300,000 offered units during the first interim period. From the second interim period until the end of the offer period, i.e. from 9.00 am (EET)...

VB10.16 in combination with atezolizumab demonstrated an ORR of 21%, including 2 CRs and 6 PRs, in a heavily pre-treated population of patients with HPV16-positive advanced cervical cancer VB10.16 in combination with atezolizumab demonstrated a very high DCR of 64% Anti-tumor activity of VB10.16 in combination with atezolizumab was observed both in PD-L1 positive patients (ORR of 27%; DCR of 77%) and PD-L1 negative patients (ORR of 17%; DCR of 58%) Management to host webcast presentation of the interim results today, May 9, 2022 at 2 p.m. CET / 8 a.m. ET OSLO, Norway, May 09, 2022 (GLOBE NEWSWIRE) — Nykode Therapeutics AS (Euronext Growth (Oslo): NYKD), a clinical-stage biopharmaceutical company dedicated to the discovery and development of vaccines and novel immunotherapies, today announced positive interim results from its Phase...